BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Aqualis ASA (Formerly Known as Clavis Pharma ASA) 

Sjølyst Plass 2

Oslo    NO-0278   Norway
Phone: 47-23-01-49-90 Fax: 47-24-11-09-51


SEARCH JOBS










 Company News
Clavis Pharma ASA Stops Elacytarabine Development on Negative Ph3 Trial in AML 4/2/2013 7:56:18 AM
Skyline Diagnostics B.V. and Clavis Pharma ASA to Collaborate on Patient Selection Biomarker Discovery for Leukemia Drug Elacytarabine 9/6/2011 12:07:52 PM
Norway's Clavis Pharma ASA Raises 19 Million Euros 11/18/2010 7:59:29 AM
Clavis Pharma ASA and Clovis Oncology Sign New $205 Million Deal For Pancreatic Cancer Drug in Asia And Rest of World 11/11/2010 7:59:20 AM
German Cancer Research Center Finds Fatty Acid to Enhance Anticancer Drug 5/7/2010 10:17:06 AM
Clavis Pharma ASA Appoints Olav Hellebo as Chief Executive Officer 1/8/2010 8:38:40 AM
Clavis Pharma ASA: Positive Phase II Clinical Data For Clavis Pharma's Elacytarabine Presented At American Society of Hematology Annual Meeting 12/7/2009 11:28:13 AM
Norway's Clavis Pharma ASA Signs $380 Million Cancer Drug Deal with Clovis Oncology (JOBS) 11/24/2009 6:48:11 AM
Clavis Pharma ASA Raises $20 Million in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug Candidates 6/26/2009 7:14:38 AM
Clavis Pharma ASA Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 6/17/2009 7:19:02 AM